| Year |
Citation |
Score |
| 2017 |
Blount RJ, Daly KR, Fong S, Chang E, Grieco K, Greene M, Stone S, Balmes J, Miller RF, Walzer PD, Huang L. Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients. Plos One. 12: e0180212. PMID 28692651 DOI: 10.1371/Journal.Pone.0180212 |
0.371 |
|
| 2013 |
Djawe K, Daly KR, Levin L, Zar HJ, Walzer PD. Humoral immune responses to Pneumocystis jirovecii antigens in HIV-infected and uninfected young children with pneumocystis pneumonia. Plos One. 8: e82783. PMID 24386119 DOI: 10.1371/Journal.Pone.0082783 |
0.355 |
|
| 2013 |
Blount RJ, Djawe K, Daly KR, Jarlsberg LG, Fong S, Balmes J, Miller RF, Walzer PD, Huang L. Ambient air pollution associated with suppressed serologic responses to Pneumocystis jirovecii in a prospective cohort of HIV-infected patients with Pneumocystis pneumonia. Plos One. 8: e80795. PMID 24236202 DOI: 10.1371/Journal.Pone.0080795 |
0.349 |
|
| 2013 |
Fong S, Daly KR, Tipirneni R, Jarlsberg LG, Djawe K, Koch JV, Swartzman A, Roth B, Walzer PD, Huang L. Antibody responses against Pneumocystis jirovecii in health care workers over time. Emerging Infectious Diseases. 19: 1612-9. PMID 24048016 DOI: 10.3201/Eid1910.121836 |
0.357 |
|
| 2013 |
Walzer PD. The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities. The Journal of Eukaryotic Microbiology. 60: 634-45. PMID 24001365 DOI: 10.1111/Jeu.12072 |
0.321 |
|
| 2013 |
Miller RF, Huang L, Walzer PD. Pneumocystis pneumonia associated with human immunodeficiency virus. Clinics in Chest Medicine. 34: 229-41. PMID 23702173 DOI: 10.1016/J.Ccm.2013.02.001 |
0.31 |
|
| 2012 |
Blount RJ, Jarlsberg LG, Daly KR, Worodria W, Davis JL, Cattamanchi A, Djawe K, Andama A, Koch J, Walzer PD, Huang L. Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms. Plos One. 7: e51545. PMID 23284710 DOI: 10.1371/Journal.Pone.0051545 |
0.359 |
|
| 2011 |
Gingo MR, Lucht L, Daly KR, Djawe K, Palella FJ, Abraham AG, Bream JH, Witt MD, Kingsley LA, Norris KA, Walzer PD, Morris A. Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia. Journal of Acquired Immune Deficiency Syndromes (1999). 57: 190-6. PMID 21372726 DOI: 10.1097/Qai.0B013E3182167516 |
0.412 |
|
| 2011 |
Crothers K, Daly KR, Rimland D, Goetz MB, Gibert CL, Butt AA, Justice AC, Djawe K, Levin L, Walzer PD. Decreased serum antibody responses to recombinant pneumocystis antigens in HIV-infected and uninfected current smokers. Clinical and Vaccine Immunology : Cvi. 18: 380-6. PMID 21191078 DOI: 10.1128/Cvi.00421-10 |
0.396 |
|
| 2010 |
Djawe K, Huang L, Daly KR, Levin L, Koch J, Schwartzman A, Fong S, Roth B, Subramanian A, Grieco K, Jarlsberg L, Walzer PD. Serum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients. Plos One. 5: e14259. PMID 21151564 DOI: 10.1371/Journal.Pone.0014259 |
0.4 |
|
| 2010 |
Djawe K, Daly KR, Vargas SL, Santolaya ME, Ponce CA, Bustamante R, Koch J, Levin L, Walzer PD. Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 14: e1060-6. PMID 20926326 DOI: 10.1016/J.Ijid.2010.07.003 |
0.377 |
|
| 2010 |
Miller RF, Evans HE, Copas AJ, Huggett JF, Edwards SG, Walzer PD. Seasonal variation in mortality of Pneumocystis jirovecii pneumonia in HIV-infected patients. International Journal of Std & Aids. 21: 497-503. PMID 20852200 DOI: 10.1258/Ijsa.2010.010148 |
0.301 |
|
| 2010 |
Cushion MT, Linke MJ, Ashbaugh A, Sesterhenn T, Collins MS, Lynch K, Brubaker R, Walzer PD. Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection. Plos One. 5: e8524. PMID 20126455 DOI: 10.1371/Journal.Pone.0008524 |
0.323 |
|
| 2009 |
Tipirneni R, Daly KR, Jarlsberg LG, Koch JV, Swartzman A, Roth BM, Walzer PD, Huang L. Healthcare worker occupation and immune response to Pneumocystis jirovecii. Emerging Infectious Diseases. 15: 1590-7. PMID 19861050 DOI: 10.3201/Eid1510.090207 |
0.337 |
|
| 2009 |
Nkinin SW, Daly KR, Walzer PD, Ndzi ES, Asonganyi T, Respaldiza N, Medrano FJ, Kaneshiro ES. Evidence for high prevalence of Pneumocystis jirovecii exposure among Cameroonians. Acta Tropica. 112: 219-24. PMID 19665440 DOI: 10.1016/J.Actatropica.2009.07.030 |
0.419 |
|
| 2009 |
Daly K, Koch J, Respaldiza N, de la Horra C, Montes-Cano MA, Medrano FJ, Varela JM, Calderon EJ, Walzer PD. Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens Clinical Microbiology and Infection. 15: 937-942. PMID 19416292 DOI: 10.1111/J.1469-0691.2009.02716.X |
0.347 |
|
| 2009 |
Walzer PD, Djawe K, Levin L, Daly KR, Koch J, Kingsley L, Witt M, Golub ET, Bream JH, Taiwo B, Morris A. Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection. The Journal of Infectious Diseases. 199: 1335-44. PMID 19301979 DOI: 10.1086/597803 |
0.416 |
|
| 2008 |
Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 625-33. PMID 18190281 DOI: 10.1086/526778 |
0.341 |
|
| 2006 |
Daly KR, Koch JV, Shire NJ, Levin L, Walzer PD. Human immunodeficiency virus-infected patients with prior Pneumocystis pneumonia exhibit increased serologic reactivity to several major surface glycoprotein clones Clinical and Vaccine Immunology. 13: 1071-1078. PMID 17028210 DOI: 10.1128/Cvi.00140-06 |
0.367 |
|
| 2006 |
Daly KR, Huang L, Morris A, Koch J, Crothers K, Levin L, Eiser S, Satwah S, Zucchi P, Walzer PD. Antibody response to Pneumocystis jirovecii major surface glycoprotein. Emerging Infectious Diseases. 12: 1231-7. PMID 16965702 DOI: 10.3201/Eid1708.060230 |
0.423 |
|
| 2006 |
Daly KR, Huang L, Morris A, Koch J, Crothers K, Levin L, Eiser S, Satwah S, Zucchi P, Walzer PD. Antibody Response to Pneumocystis jirovecii: Antibody Response to Pneumocystis jirovecii Major Surface Glycoprotein Emerging Infectious Diseases. 12: 1231. DOI: 10.3201/Eid1208.060230 |
0.443 |
|
| 2005 |
Vanden Eynde JJ, Mayence A, Johnson MT, Huang TL, Collins MS, Rebholz S, Walzer PD, Cushion MT, Donkor IO. Antitumor and anti-Pneumocystis carinii activities of novel bisbenzamidines Medicinal Chemistry Research. 14: 143-157. DOI: 10.1007/S00044-005-0130-2 |
0.305 |
|
| 2004 |
Daly KR, Koch J, Levin L, Walzer PD. Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci. Emerging Infectious Diseases. 10: 848-54. PMID 15200818 DOI: 10.3201/Eid1005.030497 |
0.356 |
|
| 2004 |
Thullen TD, Ashbaugh AD, Daly KR, Linke MJ, Steele PE, Walzer PD. Sensitized splenocytes result in deleterious cytokine cascade and hyperinflammatory response in rats with Pneumocystis pneumonia despite the presence of corticosteroids. Infection and Immunity. 72: 757-65. PMID 14742518 DOI: 10.1128/Iai.72.2.757-765.2004 |
0.718 |
|
| 2003 |
Thullen TD, Walzer PD. Large doses of major surface glycoprotein-sensitized donor splenocytes transferred to corticosteroid treated rats with Pneumocystis pneumonia result in successful reduction of organism burden. The Journal of Eukaryotic Microbiology. 50: 666-7. PMID 14736210 DOI: 10.1111/J.1550-7408.2003.Tb00677.X |
0.729 |
|
| 2003 |
Thullen TD, Ashbaugh AD, Daly KR, Linke MJ, Steele PE, Walzer PD. New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies. Infection and Immunity. 71: 6292-7. PMID 14573648 DOI: 10.1128/Iai.71.11.6292-6297.2003 |
0.728 |
|
| 2002 |
Daly KR, Fichtenbaum CJ, Tanaka R, Linke MJ, O'Bert R, Thullen TD, Hui MS, Smulian AG, Walzer PD. Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons. The Journal of Infectious Diseases. 186: 644-51. PMID 12195351 DOI: 10.1086/341565 |
0.725 |
|
| 2002 |
Walzer PD, Ashbaugh A. Use of terbinafine in mouse and rat models of Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy. 46: 514-6. PMID 11796365 DOI: 10.1128/Aac.46.2.514-516.2002 |
0.377 |
|
| 2001 |
Walzer PD, Ashbaugh A, Collins M, Cushion MT. Anti-human immunodeficiency virus drugs are ineffective against Pneumocystis carinii in vitro and in vivo Journal of Infectious Diseases. 184: 1355-1357. PMID 11679930 DOI: 10.1086/323991 |
0.356 |
|
| 2001 |
Linke MJ, Harris CE, Korfhagen TR, McCormack FX, Ashbaugh AD, Steele P, Whitsett JA, Walzer PD. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection Journal of Infectious Diseases. 183: 943-952. PMID 11237812 DOI: 10.1086/319252 |
0.31 |
|
| 2000 |
Dohn MN, White ML, Vigdorth EM, Ralph Buncher C, Hertzberg VS, Baughman RP, George Smulian A, Walzer PD. Geographic clustering of Pneumocystis carinii pneumonia in patients with HIV infection. American Journal of Respiratory and Critical Care Medicine. 162: 1617-21. PMID 11069785 DOI: 10.1164/Ajrccm.162.5.9707101 |
0.339 |
|
| 1999 |
Walzer PD. Immunological features of Pneumocystis carinii infection in humans Clinical and Diagnostic Laboratory Immunology. 6: 149-155. PMID 10066645 DOI: 10.1128/Cdli.6.2.149-155.1999 |
0.361 |
|
| 1998 |
Theus SA, Smulian AG, Steele P, Linke MJ, Walzer PD. Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Vaccine. 16: 1149-57. PMID 9682373 DOI: 10.1016/S0264-410X(98)80113-8 |
0.394 |
|
| 1998 |
De Stefano JA, Myers JD, Du Pont D, Foy JM, Theus SA, Walzer PD. Cell wall antigens of Pneumocystis carinii trophozoites and cysts: purification and carbohydrate analysis of these glycoproteins. The Journal of Eukaryotic Microbiology. 45: 334-43. PMID 9627993 DOI: 10.1111/J.1550-7408.1998.Tb04545.X |
0.387 |
|
| 1998 |
Broomall KR, Morris RE, Walzer PD, Smulian AG. Zymolyase treatment exposes p55 antigen of Pneumocystis carinii. The Journal of Eukaryotic Microbiology. 45: 284-9. PMID 9627988 DOI: 10.1111/J.1550-7408.1998.Tb04537.X |
0.376 |
|
| 1998 |
Theus SA, Sawhney N, Smulian AG, Walzer PD. Proliferative and cytokine responses of human T lymphocytes isolated from human immunodeficiency virus-infected patients to the major surface glycoprotein of Pneumocystis carinii. The Journal of Infectious Diseases. 177: 238-41. PMID 9419198 DOI: 10.1086/517363 |
0.399 |
|
| 1997 |
Theus SA, Walzer PD. Adoptive transfer of specific lymphocyte populations sensitized to the major surface glycoprotein of Pneumocystis carinii decreases organism burden while increasing survival rate in the rat Journal of Eukaryotic Microbiology. 44. PMID 9508414 DOI: 10.1111/J.1550-7408.1997.Tb05750.X |
0.331 |
|
| 1997 |
Walzer PD. Pneumocystis carinii pneumonia in patients without human immunodeficiency virus infection Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 25: 219-220. PMID 9332514 DOI: 10.1086/514541 |
0.314 |
|
| 1997 |
Theus SA, Smulian AG, Sullivan DW, Walzer PD. Cytokine responses to the native and recombinant forms of the major surface glycoprotein of Pneumocystis carinii Clinical and Experimental Immunology. 109: 255-260. PMID 9276520 DOI: 10.1046/J.1365-2249.1997.4501348.X |
0.344 |
|
| 1997 |
Theus SA, Andrews RP, Linke MJ, Walzer PD. Characterization of rat CD4 T cell clones specific for the major surface glycoprotein of Pneumocystis carinii. The Journal of Eukaryotic Microbiology. 44: 96-100. PMID 9109259 DOI: 10.1111/J.1550-7408.1997.Tb05944.X |
0.374 |
|
| 1997 |
Walzer PD, Runck J, Steele P, White M, Linke MJ, Sidman CL. Immunodeficient and immunosuppressed mice as models to test anti- Pneumocystis carinii drugs Antimicrobial Agents and Chemotherapy. 41: 251-258. PMID 9021175 DOI: 10.1128/Aac.41.2.251 |
0.316 |
|
| 1995 |
Theus SA, Andrews RP, Steele P, Walzer PD. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat. The Journal of Clinical Investigation. 95: 2587-93. PMID 7769101 DOI: 10.1172/Jci117960 |
0.418 |
|
| 1995 |
Keely SP, Stringer JR, Baughman RP, Linke MJ, Walzer PD, Smulian AG. Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis. The Journal of Infectious Diseases. 172: 595-8. PMID 7542688 DOI: 10.1093/Infdis/172.2.595 |
0.3 |
|
| 1994 |
De Stefano JA, Foy JM, Sullivan DW, Dawes SM, Cushion MT, Babcock GF, Sleight RG, van Halbeek H, Walzer PD. Fractionation of Pneumocystis carinii developmental stages by counterflow centrifugal elutriation and sequential filtrations. Parasitology Research. 80: 1-9. PMID 8153118 DOI: 10.1007/Bf00932616 |
0.333 |
|
| 1994 |
Theus SA, Sullivan DW, Walzer PD, Smulian AG. Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen Infection and Immunity. 62: 3479-3484. PMID 8039919 DOI: 10.1128/Iai.62.8.3479-3484.1994 |
0.394 |
|
| 1994 |
Walzer PD, Foy J, Runck J, Steele P, White M, Klein RS, Otter BA, Sundberg RJ. Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats. Antimicrobial Agents and Chemotherapy. 38: 2572-6. PMID 7872750 DOI: 10.1128/Aac.38.11.2572 |
0.321 |
|
| 1994 |
Linke MJ, Smulian AG, Stringer JR, Walzer PD. Characterization of multiple unique cDNAs encoding the major surface glycoprotein of rat-derived Pneumocystis carinii. Parasitology Research. 80: 478-86. PMID 7808998 DOI: 10.1007/Bf00932694 |
0.331 |
|
| 1993 |
Smulian AG, Sullivan DW, Linke MJ, Halsey NA, Quinn TC, MacPhail AP, Avila MAH, Hong ST, Walzer PD. Geographic Variation in the Humoral Response to Pneumocystis carinii Journal of Infectious Diseases. 167: 1243-1247. PMID 8486964 DOI: 10.1093/Infdis/167.5.1243 |
0.376 |
|
| 1993 |
Smulian AG, Theus SA, Denko N, Walzer PD, Stringer JR. A 55 kDa antigen of Pneumocystis carinii: analysis of the cellular immune response and characterization of the gene. Molecular Microbiology. 7: 745-53. PMID 8469116 DOI: 10.1111/J.1365-2958.1993.Tb01165.X |
0.363 |
|
| 1993 |
Theus SA, Linke MJ, Andrews RP, Walzer PD. Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii. Infection and Immunity. 61: 4703-9. PMID 8406869 DOI: 10.1128/Iai.61.11.4703-4709.1993 |
0.416 |
|
| 1993 |
Rice WR, Singleton FM, Linke MJ, Walzer PD. Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat Journal of Clinical Investigation. 92: 2778-2782. PMID 8254031 DOI: 10.1172/Jci116896 |
0.326 |
|
| 1993 |
Walzer PD, Whimbey E. Overview of Prevention of Infections in the Immunocompromised Patient Clinical Infectious Diseases. 17: S376-S377. DOI: 10.1093/Clinids/17.Supplement_2.S376 |
0.308 |
|
| 1992 |
De Stefano JA, Sleight RG, Babcock GF, Michael Sramkoski R, Walzer PD. Isolation of Pneumocystis carinii cysts by flow cytometry Parasitology Research. 78: 179-182. PMID 1589425 DOI: 10.1007/Bf00931724 |
0.301 |
|
| 1992 |
De Stefano JA, Trinkle LS, Walzer PD, Cushion MT. Flow cytometric analyses of lectin binding to Pneumocystis carinii surface carbohydrates Journal of Parasitology. 78: 271-280. PMID 1556643 DOI: 10.2307/3283474 |
0.313 |
|
| 1992 |
Smulian AG, Walzer PD. The biology of Pneumocystis carinii. Critical Reviews in Microbiology. 18: 191-216. PMID 1554424 DOI: 10.3109/10408419209114558 |
0.364 |
|
| 1992 |
Smulian AG, Stringer JR, Linke MJ, Walzer PD. Isolation and characterization of a recombinant antigen of Pneumocystis carinii. Infection and Immunity. 60: 907-15. PMID 1541564 DOI: 10.1128/Iai.60.3.907-915.1992 |
0.421 |
|
| 1992 |
Walzer PD, Foy J, Steele P, Kim CK, White M, Klein RS, Otter BA, Allegra C. Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy. 36: 1935-42. PMID 1416884 DOI: 10.1128/Aac.36.9.1935 |
0.347 |
|
| 1991 |
Walzer PD, Kim CK, Foy J, Zhang JL. Furazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy. 35: 158-63. PMID 2014971 DOI: 10.1128/Aac.35.1.158 |
0.365 |
|
| 1991 |
Walzer PD. Pneumocystis carinii - New clinical spectrum? New England Journal of Medicine. 324: 263-265. PMID 1985248 DOI: 10.1056/Nejm199101243240411 |
0.353 |
|
| 1990 |
Peglow SL, Smulian AG, Linke MJ, Pogue CL, Nurre S, Crisler J, Phair J, Gold JW, Armstrong D, Walzer PD. Serologic responses to Pneumocystis carinii antigens in health and disease. The Journal of Infectious Diseases. 161: 296-306. PMID 2299209 DOI: 10.1093/Infdis/161.2.296 |
0.37 |
|
| 1990 |
De Stefano JA, Cushion MT, Sleight RG, Walzer PD. Analysis of Pneumocystis carinii cyst wall I. Evidence for an outer surface membrane Journal of Protozoology. 37: 428-435. PMID 2213655 DOI: 10.1111/J.1550-7408.1990.Tb01167.X |
0.309 |
|
| 1990 |
Hong ST, Steele PE, Cushion MT, Walzer PD, Stringer SL, Stringer JR. Pneumocystis carinii karyotypes. Journal of Clinical Microbiology. 28: 1785-95. PMID 1975595 DOI: 10.1128/Jcm.28.8.1785-1795.1990 |
0.329 |
|
| 1989 |
De Stefano JA, Cushion MT, Trinkle LS, Walzer PD. Lectins as probes to Pneumocystis carinii surface glycocomplexes Journal of Protozoology. 36. PMID 2785201 DOI: 10.1111/J.1550-7408.1989.Tb02704.X |
0.315 |
|
| 1989 |
Linke MJ, Walzer PD. Analysis of a surface antigen of Pneumocystis carinii Journal of Protozoology. 36. PMID 2785200 DOI: 10.1111/J.1550-7408.1989.Tb02701.X |
0.356 |
|
| 1989 |
Walzer PD, Cushion MT. Immunobiology of Pneumocystis carinii Pathology and Immunopathology Research. 8: 127-140. PMID 2671972 DOI: 10.1159/000157145 |
0.343 |
|
| 1989 |
Linke MJ, Cushion MT, Walzer PD. Properties of the major antigens of rat and human Pneumocystis carinii Infection and Immunity. 57: 1547-1555. PMID 2651312 DOI: 10.1128/Iai.57.5.1547-1555.1989 |
0.376 |
|
| 1989 |
Walzer PD, Kim CK, Linke MJ, Pogue CL, Huerkamp MJ, Chrisp CE, Lerro AV, Wixson SK, Hall E, Shultz LD. Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice Infection and Immunity. 57: 62-70. PMID 2642471 DOI: 10.1128/Iai.57.1.62-70.1989 |
0.342 |
|
| 1988 |
Walzer PD, Kim CK, Foy JM, Linke MJ, Cushion MT. Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy. 32: 96-103. PMID 3258144 DOI: 10.1128/Aac.32.1.96 |
0.305 |
|
| 1988 |
Cushion MT, DeStefano JA, Walzer PD. Pneumocystis carinii: Surface reactive carbohydrates detected by lectin probes Experimental Parasitology. 67: 137-147. PMID 3142787 DOI: 10.1016/0014-4894(88)90061-6 |
0.321 |
|
| 1988 |
Walzer PD, Kim CK, Foy J, Linke MJ, Cushion MT. Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy. 32: 896-905. PMID 3137861 DOI: 10.1128/Aac.32.6.896 |
0.355 |
|
| 1988 |
Hagler DN, Deepe GS, Pogue CL, Walzer PD. Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection Clinical and Experimental Immunology. 74: 7-13. PMID 2975540 |
0.322 |
|
| 1988 |
Walzer PD. Perspective diagnosis of pneumocystis carinii pneumonia Journal of Infectious Diseases. 157: 629-632. PMID 2450152 DOI: 10.1093/Infdis/157.4.629 |
0.355 |
|
| 1987 |
Walzer PD, Stanforth D, Linke MJ, Cushion MT. Pneumocystis carinii: Immunoblotting and immunofluorescent analyses of serum antibodies during experimental rat infection and recovery Experimental Parasitology. 63: 319-328. PMID 3556208 DOI: 10.1016/0014-4894(87)90179-2 |
0.406 |
|
| 1987 |
Walzer PD, Linke MJ. A comparison of the antigenic characteristics of rat and human Pneumocystis carinii by immunoblotting Journal of Immunology. 138: 2257-2265. PMID 3549900 |
0.313 |
|
| 1987 |
Kim CK, Foy JM, Cushion MT, Stanforth D, Linke MJ, Hendrix HL, Walzer PD. Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy. 31: 197-201. PMID 3494426 DOI: 10.1128/Aac.31.2.197 |
0.357 |
|
| 1987 |
Douce RW, Brown AE, Khamboonruang C, Walzer PD, Genta RM. Seroepidemiology of strongyloidiasis in a thai village International Journal For Parasitology. 17: 1343-1348. PMID 3429125 DOI: 10.1016/0020-7519(87)90101-9 |
0.349 |
|
| 1987 |
Sullivan R, Linneman CC, Clark CS, Walzer PD. Seroepidemiologic study of giardiasis patients and high-risk groups in a midwestern city in the United States American Journal of Public Health. 77: 960-963. PMID 2886069 DOI: 10.2105/Ajph.77.8.960 |
0.348 |
|
| 1987 |
Genta RM, Walzer PD, Weesner RE. In Reply Jama: the Journal of the American Medical Association. 258: 3259. DOI: 10.1001/Jama.1987.03400220058032 |
0.303 |
|
| 1986 |
Genta RM, Douce RW, Walzer PD. Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis Journal of Clinical Microbiology. 23: 1099-1103. PMID 3711300 DOI: 10.1128/Jcm.23.6.1099-1103.1986 |
0.354 |
|
| 1986 |
Ruffolo JJ, Cushion MT, Walzer PD. Techniques for examining Pneumocystis carinii in fresh specimens Journal of Clinical Microbiology. 23: 17-21. PMID 2422197 DOI: 10.1128/Jcm.23.1.17-21.1986 |
0.326 |
|
| 1985 |
Cushion MT, Stanforth D, Linke MJ, Walzer PD. Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro Antimicrobial Agents and Chemotherapy. 28: 796-801. PMID 3936409 DOI: 10.1128/Aac.28.6.796 |
0.334 |
|
| 1984 |
Cushion MT, Walzer PD. Cultivation of Pneumocystis carinii in lung-derived cell lines Journal of Infectious Diseases. 149: 644. PMID 6610000 DOI: 10.1093/Infdis/149.4.644 |
0.314 |
|
| 1984 |
Cushion MT, Walzer PD. Growth and serial passage of Pneumocystis carinii in the A549 cell line Infection and Immunity. 44: 245-251. PMID 6609125 DOI: 10.1128/Iai.44.2.245-251.1984 |
0.334 |
|
| 1984 |
Walzer PD, Young LS. Clinical relevance of animal models of Pneumocystis carinii pneumonia Diagnostic Microbiology and Infectious Disease. 2: 1-6. PMID 6336147 DOI: 10.1016/0732-8893(84)90016-6 |
0.355 |
|
| 1984 |
Walzer PD, LaBine M, Redington TJ, Cushion MT. Predisposing factors in Pneumocystis carinii pneumonia: Effects of tetracycline, protein malnutrition, and corticosteroids on hosts Infection and Immunity. 46: 747-753. PMID 6334032 DOI: 10.1128/Iai.46.3.747-753.1984 |
0.374 |
|
| 1983 |
Genta RM, Ottesen EA, Neva FA, Walzer PD, Tanowitz HB, Wittner M. Cellular responses in human strongyloidiasis American Journal of Tropical Medicine and Hygiene. 32: 990-994. PMID 6625079 DOI: 10.4269/Ajtmh.1983.32.990 |
0.342 |
|
| 1983 |
Rankin JA, Walzer PD, Dwyer JM, Schrader CE, Enriquez RE, Merrill WW. Immunologic alterations in bronchoalveolar lavage fluid in the acquired immunodeficiency syndrome (AIDS) American Review of Respiratory Disease. 128: 189-194. PMID 6307101 DOI: 10.1164/Arrd.1983.128.1.189 |
0.346 |
|
| 1982 |
Walzer PD, Rutledge ME. Serum antibody responses to Pneumocystis carinii among different strains of normal and athymic mice Infection and Immunity. 35: 620-626. PMID 6976938 DOI: 10.1128/Iai.35.2.620-626.1982 |
0.377 |
|
| 1981 |
Stahr BJ, Walzer PD, Yoneda K. Effect of proteolytic enzymes on Pneumocystis carinii in rat lung tissue Journal of Parasitology. 67: 196-203. PMID 7017097 DOI: 10.2307/3280635 |
0.365 |
|
| 1981 |
Walzer PD, Rutledge ME. Humoral immunity in experimental Pneumocystis carinii infection. I. Serum and bronchial lavage fluid antibody responses in rats The Journal of Laboratory and Clinical Medicine. 97: 820-833. PMID 7014742 |
0.355 |
|
| 1980 |
Walzer PD, Rutledge ME. Comparison of rat, mouse, and human Pneumocystis carinii by immunofluorescence Journal of Infectious Diseases. 142: 449. PMID 6969280 DOI: 10.1093/Infdis/142.3.449 |
0.349 |
|
| 1980 |
Walzer PD, Powell RD, Yoneda K, Rutledge ME, Milder JE. Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia Infection and Immunity. 27: 928-937. PMID 6966614 DOI: 10.1128/Iai.27.3.928-937.1980 |
0.377 |
|
| 1980 |
Milder JE, Walzer PD, Coonrod JD, Rutledge ME. Comparison of histological and immunological techniques for detection of Pneumocystis carinii in rat bronchial lavage fluid Journal of Clinical Microbiology. 11: 409-417. PMID 6154719 DOI: 10.1128/Jcm.11.4.409-417.1980 |
0.38 |
|
| 1979 |
Singer C, Armstrong D, Rosen PP, Walzer PD, Yu B. Diffuse pulmonary infiltrates in immunosuppressed patients. Prospective study of 80 cases The American Journal of Medicine. 66: 110-120. PMID 420237 DOI: 10.1016/0002-9343(79)90490-X |
0.323 |
|
| 1979 |
Walzer PD, Rutledge ME, Yoneda K, Stahr BJ. Pneumocystis carinii: New separation method from lung tissue Experimental Parasitology. 47: 356-368. PMID 221230 DOI: 10.1016/0014-4894(79)90088-2 |
0.313 |
|
| 1977 |
Walzer PD. Pneumocystis carinii infection Southern Medical Journal. 70: 1330-1337. PMID 303379 DOI: 10.1007/978-1-4757-9313-0_14 |
0.381 |
|
| 1977 |
Walzer PD, Schnelle V, Armstrong D, Rosen PP. Nude mouse: a new experimental model for Pneumocystis carinii infection Science. 197: 177-179. PMID 301657 DOI: 10.1126/Science.301657 |
0.39 |
|
| 1976 |
Healy GR, Walzer PD, Sulzer AJ. A case of asymptomatic babesiosis in Georgia American Journal of Tropical Medicine and Hygiene. 25: 376-378. PMID 945702 DOI: 10.4269/Ajtmh.1976.25.376 |
0.301 |
|
| 1974 |
Fu SM, Winchester RJ, Feizi T, Walzer PD, Kunkel HG. Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 71: 4487-90. PMID 4612522 DOI: 10.1073/Pnas.71.11.4487 |
0.322 |
|
| Show low-probability matches. |